Article Details

Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for ...

Retrieved on: 2022-07-21 16:07:48

Tags for this article:

Click the tags to see associated articles and topics

Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for .... View article details on hiswai:

Excerpt

(Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for the treatment of peripheral ...

Article found on: www.hastingstribune.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up